Skip to main content
JOONGANG ADVANCED MATERIALS Co., Ltd logo

JOONGANG ADVANCED MATERIALS Co., Ltd — Investor Relations & Filings

Ticker · 051980 ISIN · KR7051980001 KO Manufacturing
Open in API
Filings indexed 639 across all filing types
Latest filing 2020-03-20 Audit Report / Informat…
Country KR South Korea
Listing KO 051980

About JOONGANG ADVANCED MATERIALS Co., Ltd

http://www.jamaterials.com

JOONGANG ADVANCED MATERIALS Co., Ltd. is a manufacturer engaged in two primary business segments: communications equipment and building materials. The company develops, produces, and markets wired communication equipment and optical components for the telecommunications sector. In its building materials division, it manufactures and distributes a range of PVC products, including windows and doors, as well as ventilation systems. The company's portfolio also includes plastic products, LED lighting, and medical devices.

Recent filings

Filing Released Lang Actions
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변동
Audit Report / Information Classification · 95% confidence The document is a regulatory filing from the Korea Exchange (KRX) system, specifically a 'Correction Report' (정정신고) regarding a previous disclosure of 'Changes in Sales or Profit/Loss Structure of 30% or more'. This type of filing is a standard regulatory requirement in South Korea for listed companies to update financial performance data following an audit. Since it is a specific regulatory disclosure regarding financial results and not a full annual report or a simple announcement of a report's publication, it falls under the 'Regulatory Filings' category. FY 2019
2020-03-20 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Central Bio. It outlines the date, location, and agenda items (such as approval of financial statements, election of directors, and remuneration limits). This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the upcoming meeting and the matters to be voted upon.
2020-03-13 Korean
주주총회집중일개최사유신고
Regulatory Filings Classification · 95% confidence The document is a formal regulatory filing submitted to the KRX (Korea Exchange) regarding the scheduling of a General Meeting of Shareholders on a 'concentrated date'. It explains the company's inability to avoid the peak date due to internal scheduling constraints. Since this is a specific regulatory disclosure required by the exchange regarding meeting logistics rather than the meeting materials themselves or a proxy statement, it falls under the general regulatory filing category.
2020-03-13 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for Central Bio. It contains the meeting agenda, details on board member elections, financial statement approval, and governance information (director activities). This is a standard proxy statement/notice document sent to shareholders to inform them of the upcoming AGM and solicit their votes. In the context of the provided filing categories, this aligns with the Proxy Solicitation & Information Statement (PSI) category, as it serves to provide information and request votes for the meeting.
2020-03-13 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Reference Document' (참고서류) for the 21st Annual General Meeting (AGM) of Central Bio Co., Ltd. It contains information regarding the solicitation of proxy votes, details about the board and management, and the agenda items for the meeting, including the approval of financial statements. This is a standard proxy solicitation document provided to shareholders to inform them of the meeting agenda and request their votes, which falls under the Proxy Solicitation & Information Statement category.
2020-03-13 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Management Reports Classification · 95% confidence The document is a regulatory filing from a Korean company (Central Bio) announcing a significant change (over 30%) in revenue or profit structure. This is a standard disclosure requirement for listed companies in Korea (often referred to as a 'Fair Disclosure' or 'Significant Change' filing). Since it provides specific financial highlights and reasons for the change rather than just announcing the availability of a report, it falls under the category of general regulatory filings.
2020-02-17 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.